Question

Difficulty: HardCardiovascular System

A 72-year-old man is brought to the emergency department due to the sudden onset of severe shortness of breath and a cough productive of pink, frothy sputum that began 11 hour ago. He has a history of ischemic cardiomyopathy with a left ventricular ejection fraction of 35%35\%, mild chronic obstructive pulmonary disease (COPD), and poorly controlled hypertension. His current medications include lisinopril, metoprolol succinate, aspirin, and a tiotropium inhaler. His temperature is 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure is 220/120220/120 mmHg, pulse is 115115/min, and respirations are 3232/min. Pulse oximetry shows 84%84\% on room air. The patient is alert, oriented, and speaks in short, gasping phrases. Physical examination reveals use of accessory muscles of respiration. Auscultation of the lungs reveals diffuse, high-pitched expiratory wheezes bilaterally with no audible crackles. Cardiovascular examination reveals a regular tachycardia with a prominent S4S_4 gallop. There is no jugular venous distention or lower extremity edema. An arterial blood gas analysis on room air shows:

Laboratory ParameterResult
pH7.257.25
PaCO2_26565 mmHg
PaO2_25050 mmHg
HCO3−_3^-2828 mEq/L

Which of the following is the most appropriate next step in management?

  1. A
    Inhaled albuterol and intravenous methylprednisolone
  2. B
    Intravenous ceftriaxone and azithromycin
  3. C
    Intravenous metoprolol and furosemide
  4. Noninvasive positive pressure ventilation and intravenous nitroglycerinAnswer
  5. E
    Immediate endotracheal intubation

Answer

The correct intervention is noninvasive positive pressure ventilation (NIPPV) and intravenous nitroglycerin.
The patient is experiencing Sympathetic Crashing Acute Pulmonary Edema (SCAPE), a severe form of acute decompensated heart failure characterized by abrupt, extreme hypertension and flash pulmonary edema. The rapid accumulation of fluid in the peribronchial spaces compresses the airways, leading to expiratory wheezing known as 'cardiac asthma.' This must be differentiated from a COPD exacerbation. The presence of sudden-onset severe hypertension, pink frothy sputum, and an S4 gallop strongly supports a cardiogenic etiology rather than a primary pulmonary process. In SCAPE, the extreme afterload drives fluid into the alveoli. The immediate treatment goals are to reduce afterload and decrease the work of breathing. Noninvasive positive pressure ventilation (NIPPV) provides positive end-expiratory pressure, which splints airways open, improves oxygenation, and reduces both preload and afterload. Intravenous nitroglycerin acts as a rapid vasodilator, primarily reducing afterload at high doses, making it the ideal pharmacologic agent to break the cycle of sympathetic overtone.

Step-by-Step Solution

1
Analyze the clinical presentation and vital signs.
The patient presents with severe hypertension (220/120220/120 mmHg), hypoxia, respiratory acidosis, pink frothy sputum, and an S4S_4 gallop.
Identifying the constellation of extreme hypertension and abrupt respiratory failure establishes the diagnosis of flash pulmonary edema.
2
Differentiate the cause of wheezing.
The wheezing is recognized as 'cardiac asthma' caused by peribronchial edema, rather than a primary COPD exacerbation.
Although the patient has a history of COPD, the lack of fever, presence of a new S4S_4, and pink frothy sputum rule out an infectious pulmonary exacerbation.
3
Determine the optimal immediate therapeutic interventions.
Select NIPPV for respiratory support and IV nitroglycerin for rapid blood pressure control.
In Sympathetic Crashing Acute Pulmonary Edema (SCAPE), reducing extreme afterload is the primary mechanism to halt fluid shift into the alveoli, while NIPPV splints the airways open.

Key Concept

Differentiating cardiac asthma from COPD exacerbation and managing Sympathetic Crashing Acute Pulmonary Edema (SCAPE) with rapid afterload reduction and NIPPV.
Rate this question